Company Valuation: Astal Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026
Market Cap 1 34.77 64.34 118.1 401.9 747.2 2,759
Change - 85.03% 83.54% 240.29% 85.93% 269.28%
Enterprise Value (EV) 1 34.46 64.16 117.2 344.2 862.6 3,251
Change - 86.18% 82.75% 193.57% 150.59% 276.91%
P/E 577x -376x 722x 26.3x 9.45x 8.37x
PBR 0.67x 1.25x 2.27x 1.72x 2.08x 0.83x
PEG - 1x -4x 0x 0x -2.89x
Capitalization / Revenue 17.2x 30.5x 3.27x 1.7x 1.17x 1.11x
EV / Revenue 17.1x 30.4x 3.25x 1.45x 1.36x 1.31x
EV / EBITDA - - - - - -
EV / EBIT - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 0.0152 -0.0431 0.041 1.554 8.043 7.81
Distribution rate - - - - - -
Net sales 1 2.019 2.108 36.07 236.6 636.6 2,486
EBITDA - - - - - -
EBIT - - - - - -
Net income 1 0.0602 -0.1711 0.164 7.847 89.25 147.1
Net Debt 1 -0.3129 -0.1828 -0.844 -57.64 115.4 491.9
Reference price 2 8.75 16.19 29.60 40.88 76.01 65.36
Nbr of stocks (in thousands) 3,974 3,974 3,990 9,830 9,830 42,216
Announcement Date 1/9/21 8/9/22 25/8/23 12/7/24 18/8/25 7/9/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 34.82M
32.41x11.77x23.88x0.61% 1,015B
29.62x6.59x18.45x2.02% 642B
33.52x7.76x16.03x2.62% 463B
19.65x4.78x11.85x2.77% 353B
19.69x5.14x12.76x3.13% 265B
21.05x4.32x12.35x2.04% 254B
24.13x6.36x11.33x2.64% 206B
12.48x4.54x9.49x4.03% 191B
-44.28x6.46x25.23x2.25% 182B
Average 16.47x 6.41x 15.71x 2.46% 357.03B
Weighted average by Cap. 23.59x 7.64x 17.62x 2.01%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. MACINTR Stock
  4. Valuation Astal Laboratories Limited
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!